Search by Drug Name or NDC

    NDC 49502-0417-02 Adalimumab Details

    Adalimumab

    Adalimumab is a KIT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Mylan Specialty L.P.. The primary component is .

    Product Information

    NDC 49502-0417
    Product ID 49502-417_68c2c569-f3f3-4b33-8d4b-a164e78a1ae2
    Associated GPIs
    GCN Sequence Number 081263
    GCN Sequence Number Description adalimumab-fkjp SYRINGEKIT 20MG/0.4ML SUBCUT
    HIC3 S2J
    HIC3 Description ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR
    GCN 48318
    HICL Sequence Number 046685
    HICL Sequence Number Description ADALIMUMAB-FKJP
    Brand/Generic Generic
    Proprietary Name Adalimumab
    Proprietary Name Suffix n/a
    Non-Proprietary Name adalimumab
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form KIT
    Route n/a
    Active Ingredient Strength n/a
    Active Ingredient Units n/a
    Substance Name n/a
    Labeler Name Mylan Specialty L.P.
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA761154
    Listing Certified Through 2024-12-31

    Package

    NDC 49502-0417-02 (49502041702)

    NDC Package Code 49502-417-02
    Billing NDC 49502041702
    Package 2 TRAY in 1 KIT (49502-417-02) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT / 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE (49502-484-06) * 2 PACKET in 1 KIT (49502-485-06) / 1 mL in 1 PACKET
    Marketing Start Date 2023-07-02
    NDC Exclude Flag N
    Pricing Information N/A